Oculoplastics News

WAIKOLOA, Hawaii — In a presentation at Hawaiian Eye 2022, Roger A. Dailey, MD, FACS, shared his tips and tricks for performing eyelid reconstruction surgery.

In patients who had oculoplastic surgery with monitored anesthesia sedation, aromatherapy may be associated with less anxiety and pain, according to a presenter at the American Academy of Ophthalmology meeting.

Alan B. Scott, MD, a lifelong innovator and the inventor of Botox, died at age 89 years on Dec. 16, 2021, according to a social media statement from those close to him.

NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Raymond Douglas, MD, PhD, discusses results of a clinical trial examining adherence to teprotumumab and reasons for nonadherence in patients with thyroid eye disease.

A 68-year-old woman presented to the Lahey Clinic emergency room with worsening pain, swelling and redness in her right eye.

NEW ORLEANS — Teprotumumab may offer comparable proptosis efficacy in patients with thyroid eye disease with low levels of inflammation as seen in patients with higher levels of inflammatory activity, according to a study.

Teprotumumab is effective in reducing proptosis in people with thyroid eye disease more than 2 years after treatment, and initial nonresponders to teprotumumab may benefit from a second series of infusions, according to a speaker.

Treatment for thyroid eye disease should be personalized, with joint input from endocrinologists and ophthalmologists, according to two speakers.

First-line treatment of thyroid eye disease differs around the globe, with teprotumumab the most commonly prescribed treatment in North America and IV steroids most common in Europe, according to a speaker.

The ideal oculoplastics fellowship candidate is a great ophthalmologist who can quickly build rapport with patients and develop unique ways to improve surgical and clinical care.